Dec 01, 2006
The advantages of Interim Talent were among the topics covered in Ashton Tweed partner Jordan Warshafsky’s November 8 presentation to the NJ Center for Biomaterials (http://www.njbiomaterials.org) 8th New Jersey Symposium on Biomaterials Science. The biennial symposium held November 8-10 in New Brunswick, NJ offered leading biomaterials researchers the opportunity to present their recent findings to academic and industrial participants. The symposium also included the New Jersey Center for Biomaterials awards to distinguished researchers and entrepreneurs, extensive poster sessions, and a social event at Rutgers Zimmerli Museum.
Jordan presented at the event’s Industrial Members Day, a session designed to bring together participants in the Industrial Membership Group as well as Rutgers graduate students. The Industrial Membership Group facilitates industry research partnerships with Rutgers University. Jordan, who is experienced in the biomaterials field, has been a member of the Industrial Membership Group for six years. Ashton Tweed is the only interim and executive search firm to belong to the NJ Center for Biomaterials. Ashton Tweed was also the recipient of a new member recognition award.
Carmine Iovine, COO of the New Jersey Center for Biomaterials (NJCBM) Industrial Membership Program, introduced and moderated the session including a series of four diverse case histories of industrial-academic collaboration. The case histories detailed interactions with NJCBM by REVA Medical Inc. of San Diego, CA on development of radio opaque biodegradable cardiovascular stents; by Lux Biosciences of Jersey City, NJ on biodegradable polymers for ophthalmic drug delivery; by Apogee Technologies of Norwood, MA on microneedle systems for transdermal drug delivery; and by Osteotech of Eatontown, NJ on orthopaedic implants.
The Industrial Members Day session also highlighted several opportunities for partnering with companies and universities in the United Kingdom. Carole Kantor, NJCBM's Associate Director, profiled the White Rose Health Innovation Partnership (HIP), a Yorkshire, UK- based initiative that seeks to stimulate more effective innovation in the global healthcare market. Rutgers, New Jersey Institute of Technology, Princeton, and University of Medicine and Dentistry, New Jersey are working with the White Rose HIP to link existing networks, such as Biotechnology Council of New Jersey and New Jersey Technology Council, with academic-based research centers both in the US and in the UK. In the future, HIP will be funding a series of open innovation workshops, technology watch seminars, and demonstration projects.
"I am delighted that NJCBM is leading Rutgers' participation in the White Rose HIP. The technologies developed by NJCBM faculty are ripe for development, as evidenced by the existing licenses, and the HIP is a conduit for linking to other receptive academic collaborators and potential licensors," said Kantor.
Rounding out the session were presentations by Gagan Lushai, network director of BioApproaches SouthWest, an organization that supports business and professional development in the UK's southwest region Life Sciences and biotechnology sector, and by Bill Healey of Healthcare Institute of New Jersey about single use medical device legislation.
For further information about the NJCBM's Industrial Membership Program, please contact Carmine Iovine at iovine@biology.rutgers.edu.
For more information on the benefits of Interim Talent, please visit www.ashtontweed.com.
Email to friend
